New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 27, 2019 - The FDA announced the approval of Kyowa Kirin’s Nourianz (istradefylline), as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” episodes.
Download PDF
Return to publications
